Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Application of tDCS Stimulation in Controlling Refractory Status Epilepticus

NCT: NCT06344338 · RECRUITING

NCT IDNCT06344338
StatusRECRUITING
Start Date2024-04-01
Completion2026-10-01
SponsorXuanwu Hospital, Beijing (OTHER)
First posted
Last updated

Brief Summary

The purpose of the study is to assess the efficacy and safety of targeting tDCS stimulation for treatment of Refractory status epilepticus

Frequently Asked Questions

What is Application of tDCS Stimulation in Controlling Refractory Status Epilepticus?

Application of tDCS Stimulation in Controlling Refractory Status Epilepticus is a clinical trial registered under NCT06344338. Current status: RECRUITING.

What is the status of NCT06344338?

The current status of NCT06344338 (Application of tDCS Stimulation in Controlling Refractory Status Epilepticus) is: RECRUITING.

When did Application of tDCS Stimulation in Controlling Refractory Status Epilepticus start?

Application of tDCS Stimulation in Controlling Refractory Status Epilepticus started on 2024-04-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑